Aqueous humour concentrations after topical apPlication of combinEd levofloxacin-dexamethasone eye dRops and of its single components: a randoMised, assEssor-blinded, parallel-group study in patients undergoing cataract surgery: the iPERME study
Open Access
- 13 April 2020
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 76 (7) , 929-937
Abstract
Purpose To evaluate the penetration of levofloxacin and dexamethasone sodium phosphate into the aqueous humour (AH) after administration in combination and as single molecules. Evaluation of the penetration of those agents in the site of action and their pharmacodynamic potential activity in view of the intended clinical use after cataract surgery. Methods Randomised, assessor-blinded, parallel-group. Patients scheduled for cataract surgery were assigned in a 1:1:1 ratio to: levofloxacin + dexamethasone sodium phosphate (L-DSP), Levofloxacin (L) or Dexamethasone sodium phosphate (DSP) eye drops. Either test or reference drugs were instilled in the cul-de-sac twice, 90 and 60 min before paracentesis. Results A total of 125 patients completed the study. Fraction of dose absorbed in the anterior chamber was 3.8–4.2 · 10−4 for levofloxacin and 0.3–0.4 · 10−4 for dexamethasone, respectively. No notable differences in concentration of levofloxacin were found between L-DSP arm (1.970 nmol/ml) and L arm (2.151 nmol/ml). The concentrations of levofloxacin were well above the MICs for the most frequent Gram-positive and Gram-negative eye pathogens. Dexamethasone concentrations were slightly lower in L-DSP arm (0.030 nmol/ml) than in DSP arm (0.042 nmol/ml), but still in the pharmacodynamically active range in the site of action. The difference was not clinically relevant. DSP was not detected in any HA sample, suggesting its full hydrolysis to free dexamethasone. Conclusion Our results confirm that no interaction is evident on the corneal penetration of levofloxacin and dexamethasone which reach pharmacologically active concentrations when instilled as fixed combination eye drops to patients undergoing cataract surgery. Trial registration ClinicalTrials.gov Identifier: NCT03740659Keywords
Funding Information
- NTC srl, Milan – Italy (EUDRA CT code: 2018-001149-15.)
This publication has 14 references indexed in Scilit:
- Pharmacokinetics and aqueous humor penetration of levofloxacin 1.5% and moxifloxacin 0.5% in patients undergoing cataract surgeryClinical Ophthalmology, 2016
- Dexamethasone Disodium Phosphate Penetration Into the Human Aqueous Humor After Topical ApplicationCurrent Eye Research, 2015
- Antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery: Results of the 2014 ASCRS member surveyJournal of Cataract & Refractive Surgery, 2015
- Pharmacokinetics of oral vs. intravenous dexamethasone in patients hospitalized with community‐acquired pneumoniaBritish Journal of Clinical Pharmacology, 2014
- Endophthalmitis prophylaxis in cataract surgery: Overview of current practice patterns in 9 European countriesJournal of Cataract & Refractive Surgery, 2013
- Prediction of Drug Terminal Half-Life and Terminal Volume of Distribution After Intravenous Dosing Based on Drug Clearance, Steady-State Volume of Distribution, and Physiological Parameters of the BodyJournal of Pharmaceutical Sciences, 2013
- [In vitro susceptibilities to levofloxacin and various antibacterial agents of 12,866 clinical isolates obtained from 72 centers in 2010].2012
- Penetration of topically applied levofloxacin 0.5% and ofloxacin 0.3% into the vitreous of the non-inflamed human eyeGraefe's Archive for Clinical and Experimental Ophthalmology, 2006
- An in vivo study comparing the ocular absorption of levofloxacin and ciprofloxacin prior to phacoemulsificationAmerican Journal of Ophthalmology, 2004
- Ocular Absorption of Dexamethasone Phosphate Disodium by the RabbitArchives of Ophthalmology (1950), 1967